Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class ASSE: 603168

"Zhejiang Shapuaisi Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing

Sep 4, 2026 · Issued by Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A

"Zhejiang Shapuaisi Pharmaceutical Co., Ltd."Announcement on Resolutions of the 16th Meeting of the 6th Board of DirectorsAug 31
"Zhejiang Shapuaisi Pharmaceutical Co., Ltd."Announcement on Obtaining the "Drug Registration Certificate" for Vitamin B12 Eye DropsAug 8
Announcement on Release of Pledge of Shares by Actual ControllerMay 27
Announcement on Obtaining Drug Registration Certificate for Sildenafil Citrate Orally Disintegrating TabletsMay 26

All Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A news releases